Clorox Co (CLX) FinancialsCLXClorox Co

The Clorox Company (CLX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health and Wellness, accounting for 38.0% of total sales, equivalent to $634.60M. Other significant revenue streams include Household and International. Understanding this composition is critical for investors evaluating how CLX navigates market cycles within the Household Products industry.

Evaluating the bottom line, The Clorox Company maintains a gross margin of 40.66%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.89%, while the net margin is 8.57%. These profitability ratios, combined with a Return on Equity (ROE) of 285.64%, provide a clear picture of how effectively CLX converts its operational activities into shareholder value.

In the context of the broader market, CLX competes directly with industry leaders such as ELF and REYN. With a market capitalization of $12.53B, it holds a leading position in the sector. When comparing efficiency, CLX's gross margin of 40.66% stands against ELF's 83.20% and REYN's 25.95%. Such benchmarking helps identify whether The Clorox Company is trading at a premium or discount relative to its financial performance.

Clorox has shown fluctuating revenues, with Q4 2026 revenue at $1.948 billion, but a declining gross margin of 40.66% in the same quarter. Net income has also been inconsistent, with Q4 2026 net income at $167 million.